Outlook Therapeutics (NASDAQ:OTLK) lost ~81% in the premarket on Wednesday after the company announced that a clinical trial ...

Final efficacy data expected in January 2025Anticipate resubmission of BLA in calendar Q1 2025 ISELIN, N.J., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a ...

By Luis Ferré-Sadurní and Dana Rubinstein Drug addiction fueled David Andino ... By Michael Wilson Dozens of New York City renters are receiving payoffs from Blackstone in a settlement of ...

Fast Track designation indicates LBS-007’s potential in filling the unmet medical need of acute leukemiaLBS-007 is the ...

Follow the Company on its website, LinkedIn, or X. The Ocular Therapeutix logo and DEXTENZA® are registered trademarks of Ocular Therapeutix, Inc. AXPAXLITM, PAXTRAVATM, ELUTYXTM, and Ocular ...

The South Carolina Law Enforcement Division issued an endangered person alert on the behalf of the Allendale County Sheriff’s ...

Piper Sandler 36th Annual Healthcare Conference Fireside Chat Date: Tuesday, December 3rd, 2024 Fireside Chat Time: 1:30 PM ET Presenter: Pravin U. Dugel, MD, Executive Chairman, President and CEO ...

The purpose is to get important new drugs to the patient earlier ... The Company currently has four primary drug candidates under development, including LBS-008 (for Geographic Atrophy [GA] in ...

Former Chancellor of Germany Angela Merkel released her new book containing quite interesting insights into Greece's financial crisis and her relationship with the country's prime ministers, ...

Netflix announced in April 2024 that it had officially ordered and put into production a new action thriller called Ad Vitam, which translates to To Life in English. The movie has since completed ...